Bevacizumab is a vascular endothelial growth factor-A-specific angiogenesis inhibitor
indicated as an adjunct to chemotherapy for the treatment of several types of cancer …

Radiation pneumonitis and subsequent radiation pulmonary fibrosis are the two main dose-
limiting factors when irradiating the thorax that can have severe implications for patients' …

BACKGROUND: Due to a dismal prognosis of advanced lung cancer, novel screening tools
and more effective treatments are clearly needed. Lately, an increasing number of tumour …

Advanced and recurrent gynecological cancers lack effective treatment and have poor
prognosis. Besides, there is urgent need for conservative treatment for fertility protection of …

Although new treatment modalities changed the global approach to hepatocellular
carcinoma (HCC), this disease still represents a medical challenge. Currently, the …

Ganoderma lucidum Polysaccharide Peptide (Gl-PP) has shown some effects as anti-tumors
in mice and potential anti-angiogenesis. In this study, we elucidated the possible …

Angiogenesis is crucial for development and metastasis of tumors, and vascular endothelial
growth factor (VEGF) is a key mediator of this process. The importance of VEGF in …

Purpose Pazopanib, an oral angiogenesis inhibitor, is approved for the treatment of
advanced renal cell carcinoma (RCC). Response to pazopanib monotherapy varies …

The genus Ganoderma includes about 80 species growing on cut or rotten trees. The most
commonly used species is Ganoderma ludicum. Biomolecules responsible for the health …

Introduction Vascular endothelial growth factor (VEGF) plays a central role in promoting
angiogenesis and is over-expressed in breast cancer. At least four polymorphisms in the …